You cannot make promises in this business and that

You cannot make promises in this business and that’s why he is now providing ranges ..in Cytodyn’s case we are relying on outside agencies , an outsourced manufacturer and Amarex who is managing our trials and the data. So you have to take the ranges you get from Amarex on when they feel they will be done and qualify the timeframe with “ what we know today”. For the Philippines, we are depended on our partner and their communication with the government there on what they will accept and what they won’t. Because their Covid EUA processes are new, there will be confusion and a bit slow because some things will be needed to be clarified as we prepare our EUA. On NASDAQ , who knows. There have been experts on this board and others in the review of what’s going on with the debt, stock selling etc who are not in Agreement if this meets the last qualifying need or not.n the BLA, it’s a rolling BLA with the non clinical .data section being completed already and probably filed and the clinical data targeted for the beginning of q2
This is as good as we are going to get withe the nature of this industry, what Cytodyn is in control themselves, and what their outsourced vendors can provide, when.